Mecobalamin for Peripheral Neuropathy: Role in Demyelination & Nerve Repair

What Is Mecobalamin?

Mecobalamin (methylcobalamin) is the active coenzyme form of vitamin B12 — directly usable in methylation reactions without conversion. It crosses the blood-nerve barrier efficiently.

Mechanisms in Neuropathy

• Myelin synthesis: Cofactor for methionine synthase → methyl group donation for phospholipid (myelin) synthesis.
• Nerve regeneration: Promotes axonal outgrowth, Schwann cell proliferation, neurotrophic factor expression (NGF, BDNF).
• Homocysteine reduction: Lowers neurotoxic homocysteine (associated with vascular/nerve damage).
• Analgesic effects: Modulates NMDA receptors, enhances descending inhibition.

Effect on Demyelination

Mecobalamin supports remyelination by providing methyl groups for myelin lipid synthesis. However, it does not directly halt the primary demyelinating process (e.g., autoimmune attack in CIDP, MS, or toxic/metabolic stripping). Its benefit is permissive and reparative — enabling the nerve’s intrinsic repair capacity once the underlying cause is controlled.

Clinical Use

• Diabetic peripheral neuropathy: Improves somatic/autonomic symptoms, nerve conduction (RCT support).
• Alcoholic neuropathy, drug-induced (e.g., metformin, chemo): Adjunctive.
• Compression neuropathies (CTS, cubital tunnel): Post-decompression recovery.
• Not monotherapy for: CIDP, MS, GBS — require immunomodulation (IVIG, steroids, plasma exchange).

Dosing & Formulations

• Oral: 500–1500 mcg 3× daily (high-dose for neuropathy).
• IM: 500–1000 mcg 1–3×/week (bypasses absorption issues).
• Often combined with other B vitamins (B1, B6, folate).

Key Takeaway

Mecobalamin is a valuable adjunct for nerve health and regeneration, especially in metabolic/toxic/compressive neuropathies. It does not replace disease-modifying treatment for primary demyelinating disorders. Diagnose the etiology first.